A detailed history of Creative Planning transactions in Precigen, Inc. stock. As of the latest transaction made, Creative Planning holds 36,916 shares of PGEN stock, worth $35,070. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,916
Previous 33,034 11.75%
Holding current value
$35,070
Previous $47,000 23.4%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$1.27 - $1.75 $4,930 - $6,793
3,882 Added 11.75%
36,916 $58,000
Q1 2024

May 10, 2024

BUY
$1.21 - $1.75 $10,057 - $14,546
8,312 Added 33.62%
33,034 $47,000
Q4 2023

Feb 14, 2024

SELL
$0.89 - $1.41 $182,378 - $288,937
-204,920 Reduced 89.23%
24,722 $33,000
Q3 2023

Nov 16, 2023

BUY
$1.08 - $1.85 $2,306 - $3,951
2,136 Added 0.94%
229,642 $326,000
Q2 2023

Jul 21, 2023

BUY
$0.96 - $1.4 $2,687 - $3,918
2,799 Added 1.25%
227,506 $261,000
Q1 2023

May 15, 2023

SELL
$0.88 - $2.19 $1,056 - $2,628
-1,200 Reduced 0.53%
224,707 $238,000
Q4 2022

Feb 10, 2023

BUY
$1.27 - $2.26 $14,550 - $25,892
11,457 Added 5.34%
225,907 $343,000
Q2 2022

Aug 15, 2022

BUY
$1.15 - $2.53 $195,499 - $430,099
170,000 Added 382.45%
214,450 $287,000
Q4 2021

Feb 11, 2022

BUY
$3.53 - $5.5 $105,705 - $164,697
29,945 Added 206.45%
44,450 $165,000
Q3 2021

Nov 10, 2021

SELL
$4.99 - $6.55 $366,435 - $480,992
-73,434 Reduced 83.51%
14,505 $72,000
Q2 2021

Aug 04, 2021

SELL
$6.24 - $8.22 $637,459 - $839,730
-102,157 Reduced 53.74%
87,939 $573,000
Q1 2021

Apr 30, 2021

BUY
$6.74 - $10.95 $193,485 - $314,341
28,707 Added 17.79%
190,096 $1.31 Million
Q4 2020

Jan 29, 2021

BUY
$3.75 - $10.56 $56,250 - $158,400
15,000 Added 10.25%
161,389 $1.65 Million
Q3 2020

Nov 05, 2020

SELL
$3.5 - $6.2 $3,850 - $6,820
-1,100 Reduced 0.75%
146,389 $512,000
Q2 2020

Jul 23, 2020

SELL
$2.16 - $5.46 $33,832 - $85,519
-15,663 Reduced 9.6%
147,489 $736,000
Q1 2020

May 05, 2020

BUY
$1.46 - $7.19 $238,201 - $1.17 Million
163,152 New
163,152 $555,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $198M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.